WallStreetZenWallStreetZen

NASDAQ: KMTS
Kestra Medical Technologies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Kestra Medical Technologies revenue was N/A for the trailing 12 months ending Jul 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Jul 31, 2025 was $19.4M, up 12.4% from last quarter. For the last reported fiscal year 2025 ending Apr 30, 2025, KMTS annual revenue was $59.8M, with 115.1% growth year-over-year.

KMTS revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when KMTS announces revenue.

KMTS Revenue History By Year

KMTS Yearly RevenueKMTS RevenueKMTS ChangeKMTS Revenue Growth
2025-04-30$59.82M$32.00M+115.05%
2024-04-30$27.81M$20.18M+264.53%
2023-04-30$7.63MN/AN/A

1 of 1

Kestra Medical Technologies Revenue FAQ

What was KMTS's revenue last quarter?

On Invalid Date, Kestra Medical Technologies (NASDAQ: KMTS) reported Q2 2025 revenue of $19.37 million up 51.55% year over year. In the same quarter last year, Kestra Medical Technologies's revenue was $12.78 million.

What was Kestra Medical Technologies's revenue in 2025?

Kestra Medical Technologies's annual revenue for the twelve months ending Apr 30, 2025 was $59.82 million, a 115.05% increase year over year.

How much does Kestra Medical Technologies make in a day?

Based on Kestra Medical Technologies annual revenue for the past two years, KMTS makes an average of $120,039.73 per day.

What was Kestra Medical Technologies's annual revenue growth in the past year?

As of Q4 2025, Kestra Medical Technologies's revenue has grown null year over year. Kestra Medical Technologies's revenue in the past year totaled N/A.

How much does Kestra Medical Technologies make in a year?

Kestra Medical Technologies's revenue by year for the past two years is:
  • Kestra Medical Technologies's revenue for the twelve months ending Apr 30, 2025 was $59.82 million, a 115.05% increase year over year.
  • Kestra Medical Technologies's annual revenue for Apr 30, 2024 was $27.81 million, a 264.53% increase from 2023.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.